Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia

Blood

Volumn 94, Issue 2, 1999, Pages 748-753

  Schaffner, Claudia ^b   Stilgenbauer, Stephan ^b   Rappold, Gudrun A ^b   Döhner, Hartmut ^b   Lichter, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B CELL LEUKEMIA; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; MALE; MANTLE CELL LYMPHOMA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC MUTATION;

EID: 0033566329     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.2.748.414k02_748_753     Document Type: Article

References (46)

1. Sedgewick RP, Boder E: Ataxia-telangiactasia, in Vinken GBP, Klawans H (eds): Handbook of Clinical Neurology, vol 16. New York, NY, Elsevier, 1991, p 347
2. Lavin MF, Shiloh Y: The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 15:177, 1997
3. Jeggo PA, Carr AM, Lehmann AR: Splitting the ATM: Distinct repair and checkpoint defects in ataxia-telangiectasia. Trends Genet 14:312, 1998
4. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G: The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4:2025, 1995
5. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Sankhavaram RP, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor MAR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749, 1995
6. Uziel T, Savitsky K, Platzer M, Ziv Y, Helbitz T, Nehls M, Boehm T, Rosenthal A, Shiloh Y, Rotman G: Genomic organization of the ATM gene. Genomics 33:317, 1996
7. Platzer M, Rotman G, Bauer D, Uziel T, Savitsky K, Bar-Shira A, Gilad S, Rosenthal A: Ataxia-telangiectasia locus: Sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. Genome Res 7:592, 1997
8. Chen G, Lee EY-HP: The product of the ATM gene is a 370-kDa nuclear phospohoprotein. J Biol Chem 271:33693, 1996
9. Lakin ND, Weber P, Stankovic T, Rottinghaus ST, Taylor AMR, Jackson SP: Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene 13:2707, 1996
10. Brown KD, Ziv Y, Sadanandan SN, Chessa L, Collins FS, Shiloh Y, Tagle DA: The ataxia telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. Proc Natl Acad Sci US A 94:1840, 1997
11. Taylor AMR, Metcalfe JA, Thick J, Mak YF: Leukemia and lymphoma in ataxia telangiactasia. Blood 87:423, 1996
12. Morrell D, Cromartie E, Swift M: Mortality and cancer incidence in 263 patients with ataxia telangiectasia. J Natl Cancer Inst 77:89, 1986
13. Athma P, Rappaport R, Swift M: Molecular genotyping shows that ataxia-telangiactasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92:130, 1996
14. Vorechovsky I, Rasio D, Luo L, Monaco C, Hammarström L, Webster ADB, Zaloudik J, Barbanti-Brodano G, James M, Russo G, Croce CM, Negrini M: The ATM gene and susceptibility to breast cancer: Combined mutation analysis of 38 consecutive breast tumors reveals no evidence for somatic mutations and constitutional AT heterozygosity. Cancer Res 56:2726, 1996
15. FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA: Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15:307, 1997
16. Bay JO, Grancho M, Pernin D, Presneau N, Rio P, Tchirkov A, Uhrhammer N, Verrelle P, Gatti RA, Bignon YJ: No evidence for constitutional ATM mutation in breast/gastric cancer families. Int J Oncol 12:1385, 1998
17. Chen J, Birkholtz GG, Lindblom P, Rubio C, Lindblom A: The role of ataxia-telangiactasia heterozygotes in familial breast cancer. Cancer Res 58:1376, 1998
18. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, James MR, Lichter P, Döhner H: Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 3:1155, 1997
19. Vorechovsky I, Luo L, Dyer MJS, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarström L, Webster ADB, Yuille MAR: Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukemia. Nat Genet 17:96, 1997
20. Stoppa-Lyonnet D, Soulier J, Lauge A, Dastot H, Garand R, Sigaux F, Stern M-H: Inactivation of the ATM gene in T-cell prolymphocytic leukemias. Blood 91:3920, 1998
21. Yuille MAR, Coignet LJA, Abraham SM, Yaqub F, Luo L, Matutes E, Brito-Babapulle, Vorechovsky I, Dyer MJS, Catovsky D: ATM is usually rearranged in T-cell prolymphocytic leukemia. Oncogene 16:789, 1998
22. Kerangueven F, Eisinger F, Noguchi T, Allione F, Wargniez V, Eng C, Padberg G, Theillet C, Jacquemier J, Longy M, Sobol H, Birnbaum D: Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene 14:339, 1997
23. Stilgenbauer S, Liebisch P, James MR, Schröder M, Schlegelberger B, Fischer K, Bentz M, Lichter P, Döhner H: Molecular cytogenetic delineation of a noval critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders. Proc Natl Acad Sci USA 93:11837, 1996
24. Döhner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, Fischer K, Hunstein W, Lichter P: 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 89:2516, 1997
25. Gilad S, Khosravi R, Shkedy D, Uziel T, Ziv Y, Savitsky K, Rotman G, Smith S, Chessa L, Jorgensen TJ, Hamik R, Frydman M, Sanal O, Portnoi S, Doldwicz Z, Jaspers NGJ, Gatti RA, Lenoir G, Lavin MF, Tatsumi K, Wegner RD, Shiloh Y, Bar-Shira A: Predominance of null mutations in ataxia-telangiactasia. Hum Mol Genet 5:433, 1996
26. Shafman T, Khanna KK, Kedar P, Spring K, Kozlov S, Yen T, Hobson K, Gatei M, Zhang N, Watters D, Egerton M, Shiloh Y, Kharbanda S, Kufe D, Lavin MF: Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387:520, 1997
27. Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, Xu Y, Barlow C, Baltimore D, Wynshaw-Boris A, Kastan MB, Wang JY: Ataxia telangiactasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387:516, 1997
28. Appleby JM, Barber JB, Levine E, Varley JM, Taylor AM, Stankovic T, Heighway J, Warren C, Scott D: Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 76:1546, 1997
29. Banin S, Moyal L, Shieh S-Y, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y: Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674, 1998
30. Canman CE, Lim D-S, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD: Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677, 1998
31. Gilad S, Chessa L, Khosravi R, Russell P, Galanty Y, Piane M, Gatti RA, Jorgensen TJ, Shiloh Y, Bar-Shira A: Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet 62:551, 1998
32. Stankovic T, Kidd AM, Sutcliff A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Taylor AM: ATM mutations and phenotypes in ataxia-telangiactasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62:334, 1998
33. Toyoshima M, Hara T, Zhang H, Yamamoto T, Akaboshi S, Nanba E, Ohno K, Hori N, Sato K, Takeshita K: Ataxia-telangiectasia without immunodeficiency: Novel point mutations within and adjacent to the phosphatidylinositol 3-kinase-like domain. Am J Med Genet 75:141, 1998
34. Wright J, Teraoka S, Onengut S, Tolun A, Gatti RA, Ochs HD, Concannon P: A high frequency of distinkt ATM gene mutations in ataxia-telangiactasia. Am J Hum Genet 59:839, 1996
35. Xu Y, Baltimore D: Dual roles of ATM in the cellular response to radiation and in cell groth control. Genes Dev 10:2401, 1996
36. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A: Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 86:159, 1996
37. Elson A, Wang Y, Daugherty CJ, Morton CC, Zhou F, Campos-Torres J, Leder P: Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl Acad Sci USA 93:13084, 1996
38. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D: Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev 10:2411, 1996
39. Starostik P, Manshouri T, O'Brien S, Freireich E, Kantarjian H, Haidar M, Lerner S, Keating M, Albitar M: Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res 58:4552, 1998
40. Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, Moss PAH, Taylor AMR: Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 353:26, 1999
41. Bullrich F, Rasio D, Kitada S, Starostik P, Kipps T, Keating M, Albitar M, Reed JC, Croce CM: ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 59:24, 1999
42. Swift M, Morrell D, Massey RB, Chase CL: Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831, 1991
43. Easton D: Cancer risks in A-T heterozygots. Im J Radiat Biol 66:5177, 1994
44. Lim DS, Kirsch DG, Canman CE, Ahn JH, Ziv Y, Newman LS, Darnell RB, Shiloh Y, Kastan MB: ATM binds to β-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci USA 95:10146, 1998
45. Liu Q, Sommer SS: Restriction endonuclease fingerprinting (REF): A sensitive method for screening mutations in long, contiguous segments of DNA. Biotechniques 18:470, 1995
46. Beaudet AL, Tsui L-C: A suggested nomenclature for designating mutations. Hum Mutat 2:245, 1993